Dr. Elaine I. Yang is a board certified anesthesiologist and critical care physician who joined Hospital for Special Surgery after attending in the operating rooms at North Shore University Hospital in Manhasset, NY. She completed her residency at the University of California, San Francisco and her fellowship in critical care medicine at Columbia University Medical Center.
As a member of the Anesthesia Critical Care Team, Dr. Yang’s clinical expertise lies in the treatment of critically ill patients after complex surgeries and the use of ultrasonography in the routine management of these patients. Dr. Yang also has an interest in investigating determinants that increase length of stay in the recovery room.
Critical Care Ultrasonography
Ultrasound-guided Regional Anesthesia
Please do not hesitate to contact our office if you have questions regarding your insurance coverage. You may have coverage subject to the availability of 'out-of-network' benefits.
Assistant Attending Anesthesiologist, Hospital for Special Surgery
Clinical Instructor of Anesthesiology, Weill Cornell Medical College
American Society of Anesthesiologists
Society of Critical Care Medicine
New York Society of Anesthesiologists
Diplomate, American Board of Anesthesiology
Diplomate, American Board of Anesthesiology, Critical Care Medicine
Princeton Project ’55 Grant Recipient 2002
Pinkerton Foundation Research Grant Recipient 2004
NYU School of Medicine International Health Program Grant Recipient 2004
MD, New York University School of Medicine, New York, NY
Internal Medicine, Beth Israel Medical Center, New York, NY
Anesthesiology, University of California San Francisco, San Francisco, CA
Critical Care Medicine, Columbia University Medical Center, New York, NY
Yang, E & Moitra, V. Chapter 33: What is the Role of Ketamine in Perioperative Management? Evidence-Based Practice of Anesthesiology, 3rd edition, by Lee A. Fleisher MD, Publisher Saunders, Feb 27, 2013.
Yang, E. Chapter: Congenital Diaphragmatic Hernia Repair. Manual of Anesthesia Practice, 2nd edition, by John Taylor MD & Eric Lin MD, Publisher Pocket Medicine, pending publication 2014.
Chao HH, Juan SH, Liu JC, Yang HY, Yang E, Cheng TH, Shyu KG. Resveratrol inhibits angiotensin II-induced endothelin-1 gene expression and subsequent proliferation in rat aortic smooth muscle cells. European Journal of Pharmacology, 2005. 515:1-9
For more publications, please see the PubMed listing.
Yang, E & Prager, K. “Total Artificial Heart – A Bridge to Nowhere?” Critical Care/Medical Ethics Grand Rounds Conference, Columbia University Medical Center, April 2012
Yang, E. “Refractory Cerebral Edema in Acute Liver Failure.” Morbidity & Mortality Conference, Columbia University Medical Center, December 2011
Yang, E. “Methadone and the QT Interval.” Grand Rounds Presentation, University of California San Francisco, April 2010
Using midodrine, an oral vasoconstrictor, to decrease signs and symptoms of orthostatic hypotension in patients with preserved cardiac output following spine surgery.
Incidence and duration of oliguria in patients following total hip arthroplasty.
One of the goals of HSS is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
As of November 14, 2019, Dr. Yang reported no relationships with healthcare industry.
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.